Cargando…

Evaluation of in vivo antibacterial drug efficacy using Caenorhabditis elegans infected with carbapenem-resistant Klebsiella pneumoniae as a model host

Objective: This study was developed to assess the in vivo antimicrobial activity of specific drugs using a model system consisting of Caenorhabditis elegans (C. elegans) infected with Carbapenem-resistant Klebsiella pneumoniae (CRKP) in an effort to identify promising drugs for CRKP-infected patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Huijuan, Xu, Ajing, Liu, Jingxian, Wang, Fang, Yao, Huimin, Chen, Jihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439659/ https://www.ncbi.nlm.nih.gov/pubmed/36059996 http://dx.doi.org/10.3389/fphar.2022.973551

Ejemplares similares

Prediction of Prognosis in Adult Patients With Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Chen, Jihui, et al.
Publicado: (2022)

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2021)

Response of Caenorhabditis elegans during Klebsiella pneumoniae pathogenesis
por: Kamaladevi, Arumugam, et al.
Publicado: (2014)

Lipopolysaccharide exposure induces oxidative damage in Caenorhabditis elegans: protective effects of carnosine
por: Ma, Jing, et al.
Publicado: (2020)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Analysis of the Clinical Effect of Combined Drug Susceptibility to Guide Medication for Carbapenem-Resistant Klebsiella pneumoniae Patients Based on the Kirby–Bauer Disk Diffusion Method
por: Yao, Huijuan, et al.
Publicado: (2021)

A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Luterbach, Courtney L., et al.
Publicado: (2022)

Mechanisms of iron metabolism in Caenorhabditis elegans
por: Anderson, Cole P., et al.
Publicado: (2014)

Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions
por: Wang, Chenyin, et al.
Publicado: (2022)

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study
por: Fang, Jie, et al.
Publicado: (2021)

Identification and Characterization of an Antibacterial Type VI Secretion System in the Carbapenem-Resistant Strain Klebsiella pneumoniae HS11286
por: Liu, Lu, et al.
Publicado: (2017)

Curcumin supplementation increases longevity and antioxidant capacity in Caenorhabditis elegans
por: Xu, Jianing, et al.
Publicado: (2023)

The Evaluation of Geroprotective Effects of Selected Flavonoids in Drosophila melanogaster and Caenorhabditis elegans
por: Lashmanova, Ekaterina, et al.
Publicado: (2017)

Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans
por: Mohankumar, Amirthalingam, et al.
Publicado: (2022)

Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans
por: Zhang, Le, et al.
Publicado: (2022)

Simira cordifolia protects against metal induced-toxicity in Caenorhabditis elegans
por: Duran-Izquierdo, Margareth, et al.
Publicado: (2023)

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
por: Saidel-Odes, Lisa, et al.
Publicado: (2013)

No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015)

Epidemiological Study of Carbapenem-resistant Klebsiella Pneumoniae
por: Lin, Di, et al.
Publicado: (2018)

Analysis of Risk Factors and Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Wu, Cuiyun, et al.
Publicado: (2022)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

Safety and Efficacy of a Phage, kpssk3, in an in vivo Model of Carbapenem-Resistant Hypermucoviscous Klebsiella pneumoniae Bacteremia
por: Shi, Yunlong, et al.
Publicado: (2021)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
por: Chen, Xia, et al.
Publicado: (2020)

In-vitro antibacterial activity and mechanism of Monarda didyma essential oils against Carbapenem-resistant Klebsiella pneumoniae
por: Chen, Ying, et al.
Publicado: (2023)

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
por: Yuan, Youhua, et al.
Publicado: (2020)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

Host-Microbe Interactions in Caenorhabditis elegans
por: Zhang, Rui, et al.
Publicado: (2013)

A Potent Antibiotic Combination of Linezolid and Polymycin B Nonapeptide Against Klebsiella pneumoniae Infection In Vitro and In Vivo
por: Huang, Ting, et al.
Publicado: (2022)

Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer’s Disease
por: Kang, Nianxin, et al.
Publicado: (2022)

Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
por: Han, Xinhong, et al.
Publicado: (2021)

Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
por: Niu, Haofu, et al.
Publicado: (2019)

Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2017)

The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma
por: Wen, Zhongwei, et al.
Publicado: (2021)

Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19
por: Dumitru, Irina Magdalena, et al.
Publicado: (2021)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

Virulence of Klebsiella pneumoniae Isolates Harboring bla (KPC-2) Carbapenemase Gene in a Caenorhabditis elegans Model
por: Lavigne, Jean-Philippe, et al.
Publicado: (2013)

In Vivo Imaging of Caenorhabditis elegans Glycans
por: Laughlin, Scott T., et al.
Publicado: (2009)

Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae
por: Bulman, Zackery P., et al.
Publicado: (2021)

OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
por: Wong, Joshua L. C., et al.
Publicado: (2019)

Effects of chlorogenic acid on antimicrobial, antivirulence, and anti-quorum sensing of carbapenem-resistant Klebsiella pneumoniae
por: Wang, Lingbo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i4mhsqjgsthsupoiaprkmkqght